Author Correction: Discovery of toxoflavin, a potent IRE1α inhibitor acting through structure-dependent oxidative inhibition.
Jiang KL, Liu CM, Nie LT, Jiang HN, Xu L, Zhang KZ, Fan LX, Gao AH, Lin LL, Wang XY, Tan MJ, Zhang QQ, Zhou YB, Li J.
Jiang KL, et al. Among authors: fan lx.
Acta Pharmacol Sin. 2023 Dec;44(12):2550. doi: 10.1038/s41401-023-01132-4.
Acta Pharmacol Sin. 2023.
PMID: 37542201
Free PMC article.
No abstract available.